{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:13:31Z","timestamp":1793722411952,"version":"4.6.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T00:00:00Z","timestamp":1543276800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100007426","name":"Russell Berrie Nanotechnology Institute, Technion-Israel Institute of Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007426","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s13346-018-00603-0","type":"journal-article","created":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T14:32:58Z","timestamp":1543329178000},"page":"76-84","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["Amphotericin B-loaded nanoparticles for local treatment of cutaneous leishmaniasis"],"prefix":"10.1007","volume":"9","author":[{"given":"Aiman","family":"Abu Ammar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abed","family":"Nasereddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suheir","family":"Ereqat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Dan-Goor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles L.","family":"Jaffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eyal","family":"Zussman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziad","family":"Abdeen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,27]]},"reference":[{"issue":"1","key":"603_CR1","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1039\/c5cs00674k","volume":"45","author":"V Gutierrez","year":"2016","unstructured":"Gutierrez V, Seabra AB, Reguera RM, Khandare J, Calderon M. New approaches from nanomedicine for treating leishmaniasis. Chem Soc Rev. 2016;45(1):152\u201368. https:\/\/doi.org\/10.1039\/c5cs00674k .","journal-title":"Chem Soc Rev"},{"issue":"8","key":"603_CR2","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/nrmicro2608","volume":"9","author":"P Kaye","year":"2011","unstructured":"Kaye P, Scott P. Leishmaniasis: complexity at the host-pathogen interface. Nat Rev Microbiol. 2011;9(8):604\u201315. https:\/\/doi.org\/10.1038\/nrmicro2608 .","journal-title":"Nat Rev Microbiol"},{"issue":"5891","key":"603_CR3","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1126\/science.1159194","volume":"321","author":"NC Peters","year":"2008","unstructured":"Peters NC, Egen JG, Secundino N, Debrabant A, Kimblin N, Kamhawi S, et al. In vivo imaging reveals an essential role for neutrophils in leishmaniasis transmitted by sand flies. Science. 2008;321(5891):970\u20134. https:\/\/doi.org\/10.1126\/science.1159194 .","journal-title":"Science"},{"issue":"6","key":"603_CR4","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.jaad.2014.09.014","volume":"73","author":"MZ Handler","year":"2015","unstructured":"Handler MZ, Patel PA, Kapila R, Al-Qubati Y, Schwartz RA. Cutaneous and mucocutaneous leishmaniasis: differential diagnosis, diagnosis, histopathology, and management. J Am Acad Dermatol. 2015;73(6):911\u201326; 27-8. https:\/\/doi.org\/10.1016\/j.jaad.2014.09.014 .","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"603_CR5","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00253-005-1955-9","volume":"68","author":"A Lemke","year":"2005","unstructured":"Lemke A, Kiderlen AF, Kayser O. Amphotericin B. Appl Microbiol Biotechnol. 2005;68(2):151\u201362. https:\/\/doi.org\/10.1007\/s00253-005-1955-9 .","journal-title":"Appl Microbiol Biotechnol"},{"issue":"7","key":"603_CR6","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1002\/jps.21179","volume":"97","author":"JJ Torrado","year":"2008","unstructured":"Torrado JJ, Espada R, Ballesteros MP, Torrado-Santiago S. Amphotericin B formulations and drug targeting. J Pharm Sci. 2008;97(7):2405\u201325. https:\/\/doi.org\/10.1002\/jps.21179 .","journal-title":"J Pharm Sci"},{"issue":"2","key":"603_CR7","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1128\/AAC.42.2.352","volume":"42","author":"N Mbongo","year":"1998","unstructured":"Mbongo N, Loiseau PM. Billion MA, Robert-Gero M. mechanism of amphotericin B resistance in Leishmania donovani promastigotes. Antimicrob Agents Chemother. 1998;42(2):352\u20137.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"603_CR8","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.bbrc.2010.07.099","volume":"399","author":"YD Paila","year":"2010","unstructured":"Paila YD, Saha B, Chattopadhyay A. Amphotericin B inhibits entry of Leishmania donovani into primary macrophages. Biochem Biophys Res Commun. 2010;399(3):429\u201333. https:\/\/doi.org\/10.1016\/j.bbrc.2010.07.099 .","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"603_CR9","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0001-706X(01)00197-8","volume":"81","author":"P Escobar","year":"2002","unstructured":"Escobar P, Matu S, Marques C, Croft SL. Sensitivities of Leishmania species to hexadecylphosphocholine (miltefosine), ET-18-OCH(3) (edelfosine) and amphotericin B. Acta Trop. 2002;81(2):151\u20137.","journal-title":"Acta Trop"},{"issue":"1\u20133","key":"603_CR10","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S0168-3659(98)00095-9","volume":"56","author":"BG Yu","year":"1998","unstructured":"Yu BG, Okano T, Kataoka K, Sardari S, Kwon GS. In vitro dissociation of antifungal efficacy and toxicity for amphotericin B-loaded poly(ethylene oxide)-block-poly(beta benzyl L aspartate) micelles. J Control Release. 1998;56(1\u20133):285\u201391.","journal-title":"J Control Release"},{"issue":"3","key":"603_CR11","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1086\/514704","volume":"27","author":"A Wong-Beringer","year":"1998","unstructured":"Wong-Beringer A, Jacobs RA, Guglielmo BJ. Lipid formulations of amphotericin B: clinical efficacy and toxicities. Clin Infect Dis. 1998;27(3):603\u201318.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"603_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0378-5173(97)00194-4","volume":"158","author":"MS Espuelas","year":"1997","unstructured":"Espuelas MS, Legrand P, Irache JM, Gamazo C, Orecchioni AM, Devissaguet JP, et al. Poly(e-caprolacton) nanospheres as an alternative way to reduce amphotericin B toxicity. Int J Pharm. 1997;158(1):19\u201327.","journal-title":"Int J Pharm"},{"issue":"9","key":"603_CR13","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1007\/s11095-016-1948-7","volume":"33","author":"C Alvarez","year":"2016","unstructured":"Alvarez C, Shin DH, Kwon GS. Reformulation of Fungizone by PEG-DSPE micelles: deaggregation and detoxification of amphotericin B. Pharm Res. 2016;33(9):2098\u2013106. https:\/\/doi.org\/10.1007\/s11095-016-1948-7 .","journal-title":"Pharm Res"},{"issue":"4","key":"603_CR14","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s40265-016-0538-7","volume":"76","author":"NR Stone","year":"2016","unstructured":"Stone NR, Bicanic T, Salim R, Hope W. Liposomal amphotericin B (AmBisome((R))): a review of the pharmacokinetics, pharmacodynamics, clinical experience and future directions. Drugs. 2016;76(4):485\u2013500. https:\/\/doi.org\/10.1007\/s40265-016-0538-7 .","journal-title":"Drugs"},{"issue":"2","key":"603_CR15","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.jconrel.2012.01.043.","volume":"161","author":"F Danhier","year":"2012","unstructured":"Danhier F, Ansorena E, Silva JM, Coco R, Le Breton A, Preat V. PLGA-based nanoparticles: an overview of biomedical applications. J Control Release. 2012;161(2):505\u201322. https:\/\/doi.org\/10.1016\/j.jconrel.2012.01.043.","journal-title":"J Control Release"},{"issue":"1","key":"603_CR16","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.nano.2005.12.003","volume":"2","author":"CP Reis","year":"2006","unstructured":"Reis CP, Neufeld RJ, Ribeiro AJ, Veiga F. Nanoencapsulation I. methods for preparation of drug-loaded polymeric nanoparticles. Nanomedicine. 2006;2(1):8\u201321.","journal-title":"Nanomedicine"},{"issue":"3","key":"603_CR17","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/S0169-409X(02)00228-4","volume":"55","author":"J Panyam","year":"2003","unstructured":"Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev. 2003;55(3):329\u201347.","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"603_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.colsurfb.2009.09.001","volume":"75","author":"A Kumari","year":"2010","unstructured":"Kumari A, Yadav SK, Yadav SC. Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B: Biointerfaces. 2010;75(1):1\u201318. https:\/\/doi.org\/10.1016\/j.colsurfb.2009.09.001 .","journal-title":"Colloids Surf B: Biointerfaces"},{"issue":"1\u20132","key":"603_CR19","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ijpharm.2015.03.081","volume":"487","author":"Z Zhou","year":"2015","unstructured":"Zhou Z, Badkas A, Stevenson M, Lee JY, Leung YK. Herceptin conjugated PLGA-PHis-PEG pH sensitive nanoparticles for targeted and controlled drug delivery. Int J Pharm. 2015;487(1\u20132):81\u201390. https:\/\/doi.org\/10.1016\/j.ijpharm.2015.03.081 .","journal-title":"Int J Pharm"},{"issue":"4","key":"603_CR20","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1002\/chem.201503999","volume":"22","author":"MS Hudlikar","year":"2016","unstructured":"Hudlikar MS, Li X, Gagarinov IA, Kolishetti N, Wolfert MA, Boons GJ. Controlled multi-functionalization facilitates targeted delivery of nanoparticles to cancer cells. Chemistry. 2016;22(4):1415\u201323. https:\/\/doi.org\/10.1002\/chem.201503999 .","journal-title":"Chemistry"},{"issue":"1","key":"603_CR21","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4155\/tde.14.91","volume":"6","author":"DN Kapoor","year":"2015","unstructured":"Kapoor DN, Bhatia A, Kaur R, Sharma R, Kaur G, Dhawan S. PLGA: a unique polymer for drug delivery. Ther Deliv. 2015;6(1):41\u201358.","journal-title":"Ther Deliv"},{"issue":"3","key":"603_CR22","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.3390\/polym3031377","volume":"3","author":"HK Makadia","year":"2011","unstructured":"Makadia HK, Siegel SJ. Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers. 2011;3(3):1377\u201397.","journal-title":"Polymers"},{"issue":"11","key":"603_CR23","doi-asserted-by":"publisher","first-page":"3181","DOI":"10.1021\/cr940351u","volume":"99","author":"KE Uhrich","year":"1999","unstructured":"Uhrich KE, Cannizzaro SM, Langer RS, Shakesheff KM. Polymeric systems for controlled drug release. Chem Rev. 1999;99(11):3181\u201398.","journal-title":"Chem Rev"},{"issue":"21","key":"603_CR24","doi-asserted-by":"publisher","first-page":"4221","DOI":"10.1016\/S0142-9612(02)00170-9","volume":"23","author":"F Burkersroda von","year":"2002","unstructured":"von Burkersroda F, Schedl L, Gopferich A. Why degradable polymers undergo surface erosion or bulk erosion. Biomaterials. 2002;23(21):4221\u201331.","journal-title":"Biomaterials"},{"key":"603_CR25","doi-asserted-by":"publisher","unstructured":"Palma E, Pasqua A, Gagliardi A, Britti D, Fresta M, Cosco D. Antileishmanial activity of amphotericin B-loaded-PLGA nanoparticles: an overview. Materials 2018;11(7). doi: https:\/\/doi.org\/10.3390\/ma11071167 .","DOI":"10.3390\/ma11071167"},{"issue":"3","key":"603_CR26","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3109\/10717544.2014.891271","volume":"22","author":"R Kumar","year":"2015","unstructured":"Kumar R, Sahoo GC, Pandey K, Das V, Das P. Study the effects of PLGA-PEG encapsulated amphotericin B nanoparticle drug delivery system against Leishmania donovani. Drug Deliv. 2015;22(3):383\u20138. https:\/\/doi.org\/10.3109\/10717544.2014.891271 .","journal-title":"Drug Deliv"},{"key":"603_CR27","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.colsurfb.2014.01.014","volume":"116","author":"D Butani","year":"2014","unstructured":"Butani D, Yewale C, Misra A. Amphotericin B topical microemulsion: formulation, characterization and evaluation. Colloids Surf B: Biointerfaces. 2014;116:351\u20138. https:\/\/doi.org\/10.1016\/j.colsurfb.2014.01.014 .","journal-title":"Colloids Surf B: Biointerfaces"},{"issue":"19","key":"603_CR28","doi-asserted-by":"publisher","first-page":"9035","DOI":"10.1021\/acs.jmedchem.6b00955","volume":"59","author":"A Abu Ammar","year":"2016","unstructured":"Abu Ammar A, Raveendran R, Gibson D, Nassar T, Benita S. A lipophilic Pt(IV) oxaliplatin derivative enhances antitumor activity. J Med Chem. 2016;59(19):9035\u201346. https:\/\/doi.org\/10.1021\/acs.jmedchem.6b00955 .","journal-title":"J Med Chem"},{"key":"603_CR29","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.ejmech.2013.03.065","volume":"64","author":"J Ryczak","year":"2013","unstructured":"Ryczak J, Papini M, Lader A, Nasereddin A, Kopelyanskiy D, Preu L, et al. 2-Arylpaullones are selective antitrypanosomal agents. Eur J Med Chem. 2013;64:396\u2013400. https:\/\/doi.org\/10.1016\/j.ejmech.2013.03.065 .","journal-title":"Eur J Med Chem"},{"issue":"2","key":"603_CR30","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.mimet.2008.05.026","volume":"75","author":"O Shimony","year":"2008","unstructured":"Shimony O, Jaffe CL. Rapid fluorescent assay for screening drugs on Leishmania amastigotes. J Microbiol Methods. 2008;75(2):196\u2013200. https:\/\/doi.org\/10.1016\/j.mimet.2008.05.026 .","journal-title":"J Microbiol Methods"},{"issue":"9","key":"603_CR31","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1016\/j.bmcl.2015.03.027","volume":"25","author":"L Keurulainen","year":"2015","unstructured":"Keurulainen L, Siiskonen A, Nasereddin A, Kopelyanskiy D, Sacerdoti-Sierra N, Leino TO, et al. Synthesis and biological evaluation of 2-arylbenzimidazoles targeting Leishmania donovani. Bioorg Med Chem Lett. 2015;25(9):1933\u20137. https:\/\/doi.org\/10.1016\/j.bmcl.2015.03.027 .","journal-title":"Bioorg Med Chem Lett"},{"issue":"4","key":"603_CR32","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1039\/C3MD00282A","volume":"5","author":"R Haavikko","year":"2014","unstructured":"Haavikko R, Nasereddin A, Sacerdoti-Sierra N, Kopelyanskiy D, Alakurtti S, Tikka M, et al. Heterocycle-fused lupane triterpenoids inhibit Leishmania donovani amastigotes. MedChemComm. 2014;5(4):445\u201351.","journal-title":"MedChemComm"},{"issue":"1","key":"603_CR33","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1016\/0378-5173(89)90281-0","volume":"55","author":"H Fessi","year":"1989","unstructured":"Fessi H, Puisieux F, Devissaguet JP, Ammoury N, Benita S. Nanocapsule formation by interfacial polymer deposition following solvent displacement. Int J Pharm. 1989;55(1):R1\u20134.","journal-title":"Int J Pharm"},{"issue":"3","key":"603_CR34","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.jconrel.2012.05.037.","volume":"161","author":"H Ven Van de","year":"2012","unstructured":"Van de Ven H, Paulussen C, Feijens PB, Matheeussen A, Rombaut P, Kayaert P, et al. PLGA nanoparticles and nanosuspensions with amphotericin B: potent in vitro and in vivo alternatives to Fungizone and AmBisome. J Control Release. 2012;161(3):795\u2013803. https:\/\/doi.org\/10.1016\/j.jconrel.2012.05.037.","journal-title":"J Control Release"},{"issue":"4","key":"603_CR35","first-page":"110","volume":"60","author":"NA Peppas","year":"1985","unstructured":"Peppas NA. Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv. 1985;60(4):110\u20131.","journal-title":"Pharm Acta Helv"},{"issue":"3","key":"603_CR36","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.jconrel.2012.05.037","volume":"161","author":"H Ven Van de","year":"2012","unstructured":"Van de Ven H, Paulussen C, Feijens P, Matheeussen A, Rombaut P, Kayaert P, et al. PLGA nanoparticles and nanosuspensions with amphotericin B: potent in vitro and in vivo alternatives to Fungizone and AmBisome. J Control Release. 2012;161(3):795\u2013803.","journal-title":"J Control Release"},{"issue":"2","key":"603_CR37","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3109\/10837450.2014.979942","volume":"21","author":"TCMM Carraro","year":"2016","unstructured":"Carraro TCMM, Khalil NM, Mainardes RM. Amphotericin B-loaded polymeric nanoparticles: formulation optimization by factorial design. Pharm Dev Technol. 2016;21(2):140\u20136.","journal-title":"Pharm Dev Technol"},{"key":"603_CR38","doi-asserted-by":"crossref","unstructured":"Nahar M, Mishra D, Dubey V, Jain N, editors. Development of amphotericin b loaded PLGA nanoparticles for effective treatment of visceral leishmaniasis. 13th International Conference on Biomedical Engineering; 2009: Springer","DOI":"10.1007\/978-3-540-92841-6_304"},{"issue":"10","key":"603_CR39","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1128\/AAC.36.10.2310","volume":"36","author":"J Barwicz","year":"1992","unstructured":"Barwicz J, Christian S, Gruda I. Effects of the aggregation state of amphotericin B on its toxicity to mice. Antimicrob Agents Chemother. 1992;36(10):2310\u20135.","journal-title":"Antimicrob Agents Chemother"},{"key":"603_CR40","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.actbio.2016.09.036","volume":"46","author":"Y Wang","year":"2016","unstructured":"Wang Y, Ke X, Voo ZX, Yap SS, Yang C, Gao S, et al. Biodegradable functional polycarbonate micelles for controlled release of amphotericin B. Acta Biomater. 2016;46:211\u201320. https:\/\/doi.org\/10.1016\/j.actbio.2016.09.036 .","journal-title":"Acta Biomater"},{"issue":"1\u20132","key":"603_CR41","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ijpharm.2011.05.049","volume":"415","author":"S Fredenberg","year":"2011","unstructured":"Fredenberg S, Wahlgren M, Reslow M, Axelsson A. The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems\u2014a review. Int J Pharm. 2011;415(1\u20132):34\u201352. https:\/\/doi.org\/10.1016\/j.ijpharm.2011.05.049 .","journal-title":"Int J Pharm"},{"issue":"4","key":"603_CR42","first-page":"1530","volume":"42","author":"S Tsuchiya","year":"1982","unstructured":"Tsuchiya S, Kobayashi Y, Goto Y, Okumura H, Nakae S, Konno T, et al. Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester. Cancer Res. 1982;42(4):1530\u20136.","journal-title":"Cancer Res"},{"issue":"1\u20132","key":"603_CR43","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ijpharm.2014.11.042","volume":"482","author":"N Grabowski","year":"2015","unstructured":"Grabowski N, Hillaireau H, Vergnaud J, Tsapis N, Pallardy M, Kerdine-Romer S, et al. Surface coating mediates the toxicity of polymeric nanoparticles towards human-like macrophages. Int J Pharm. 2015;482(1\u20132):75\u201383. https:\/\/doi.org\/10.1016\/j.ijpharm.2014.11.042 .","journal-title":"Int J Pharm"},{"key":"603_CR44","doi-asserted-by":"publisher","first-page":"5965","DOI":"10.2147\/IJN.S82205","volume":"10","author":"AS Guedj","year":"2015","unstructured":"Guedj AS, Kell AJ, Barnes M, Stals S, Goncalves D, Girard D, et al. Preparation, characterization, and safety evaluation of poly(lactide-co-glycolide) nanoparticles for protein delivery into macrophages. Int J Nanomedicine. 2015;10:5965\u201379. https:\/\/doi.org\/10.2147\/IJN.S82205 .","journal-title":"Int J Nanomedicine"},{"issue":"1","key":"603_CR45","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.apjtm.2016.12.006","volume":"10","author":"ES Abamor","year":"2017","unstructured":"Abamor ES. Antileishmanial activities of caffeic acid phenethyl ester loaded PLGA nanoparticles against Leishmania infantum promastigotes and amastigotes in vitro. Asian Pac J Trop Med. 2017;10(1):25\u201334. https:\/\/doi.org\/10.1016\/j.apjtm.2016.12.006 .","journal-title":"Asian Pac J Trop Med"},{"issue":"6","key":"603_CR46","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1007\/s11095-009-9841-2","volume":"26","author":"JL Italia","year":"2009","unstructured":"Italia JL, Yahya MM, Singh D, Ravi Kumar MN. Biodegradable nanoparticles improve oral bioavailability of amphotericin B and show reduced nephrotoxicity compared to intravenous Fungizone. Pharm Res. 2009;26(6):1324\u201331. https:\/\/doi.org\/10.1007\/s11095-009-9841-2 .","journal-title":"Pharm Res"},{"issue":"1","key":"603_CR47","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1080\/10717544.2016.1228715","volume":"24","author":"MA Radwan","year":"2017","unstructured":"Radwan MA, AlQuadeib BT, Siller L, Wright MC, Horrocks B. Oral administration of amphotericin B nanoparticles: antifungal activity, bioavailability and toxicity in rats. Drug Deliv.\u00a02017;24(1):40\u201350. https:\/\/doi.org\/10.1080\/10717544.2016.1228715 .","journal-title":"Drug Deliv"},{"issue":"3","key":"603_CR48","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1086\/380971.","volume":"38","author":"S Sundar","year":"2004","unstructured":"Sundar S, Mehta H, Suresh AV, Singh SP, Rai M, Murray HW. Amphotericin B treatment for Indian visceral leishmaniasis: conventional versus lipid formulations. Clin Infect Dis. 2004;38(3):377\u201383. https:\/\/doi.org\/10.1086\/380971.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"603_CR49","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S0924-8579(99)00133-8","volume":"13","author":"V Yardley","year":"2000","unstructured":"Yardley V, Croft SL. A comparison of the activities of three amphotericin B lipid formulations against experimental visceral and cutaneous leishmaniasis. Int J Antimicrob Agents. 2000;13(4):243\u20138.","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"603_CR50","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.exppara.2013.07.008","volume":"135","author":"RF Carvalho de","year":"2013","unstructured":"de Carvalho RF, Ribeiro IF, Miranda-Vilela AL, de Souza Filho J, Martins OP, Cintra e Silva Dde O, et al. Leishmanicidal activity of amphotericin B encapsulated in PLGA\u2013DMSA nanoparticles to treat cutaneous leishmaniasis in C57BL\/6 mice. Exp Parasitol. 2013;135(2):217\u201322.","journal-title":"Exp Parasitol"},{"issue":"10151","key":"603_CR51","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/S0140-6736(18)31204-2","volume":"392","author":"S Burza","year":"2018","unstructured":"Burza S, Croft SL, Boelaert M. Leishmaniasis. Lancet. 2018;392(10151):951\u201370. https:\/\/doi.org\/10.1016\/S0140-6736(18)31204-2 .","journal-title":"Lancet"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13346-018-00603-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-018-00603-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-018-00603-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T12:06:12Z","timestamp":1694088372000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13346-018-00603-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,27]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["603"],"URL":"https:\/\/doi.org\/10.1007\/s13346-018-00603-0","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.739170780.793580941","asserted-by":"object"}]},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,27]]},"assertion":[{"value":"27 November 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}